Compass Therapeutics, Inc. (CMPX) (CIK 0001738021) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001193125-26-001593
- Form
- CORRESP
- Filer
- Compass Therapeutics, Inc. (CMPX) (CIK 0001738021)
- CIK
- 0001738021
- Ticker
- CMPX
- Filed
- 2026-01-05
- SIC industry
- 2836
- HQ
- Boston, MA
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1738021/000119312526001593/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer